Ligand · 319
319 · N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide
319, N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide (C20 H16 F2 N4 O3, 398.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues…
- Component
- 319
- Formula
- C20 H16 F2 N4 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
319 in 2 structures; the first of them:
- 3CTH · Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor… · 319 A2001 · binds ILE1084, VAL1092, ALA1108, LYS1110, GLU1127, ILE1130, MET1131, PHE1134 and 16 more
- 3CTH · Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor… · 319 A2001 · binds ILE1084, VAL1092, ALA1108, LYS1110, GLU1127, ILE1130, MET1131, PHE1134 and 16 more
Residues it binds most
VAL 2, LEU 2, MET 2, PHE 2, ALA 2, ILE 2, ASP 2, GLU 2, GLY 2, HIS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.